Bloodwork before a steroid cycle: what the labs actually show
Quick answer
Supraphysiologic androgen use causes cardiovascular and endocrine effects that standard bloodwork panels only partially capture. Cardiac MRI and echocardiography data show structural myocardial changes in long-term users that are invisible to a CBC or CMP. Physician-supervised monitoring with appropriate imaging is the clinical standard; social media bloodwork interpretation is not a substitute.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption and creator handle, @thegorillapharma_ is almost certainly walking viewers through a bloodwork protocol for anabolic steroid cycles. The typical version of this content covers a pre-cycle baseline panel (testosterone, LH, FSH, hematocrit, lipids, liver enzymes), mid-cycle monitoring (mostly hematocrit and blood pressure), and post-cycle recovery markers. The creator is also pitching DM consultations to help people interpret their specific results, which is a common monetization path in this corner of fitness TikTok. The framing that bloodwork makes steroid use "safe" is the real claim worth scrutinizing. It isn't wrong that monitoring matters, but the jump from "get tested" to "stay healthy" glosses over outcomes that labs simply cannot predict or prevent, including myocardial fibrosis, sudden cardiac events, and psychiatric effects. The implied message that informed self-management equals clinical management is where this content gets medically slippery.
What does the science actually show?
The evidence that supraphysiologic androgen use causes measurable cardiovascular harm is not subtle. Baggish et al. (2017, Circulation) used cardiac MRI to show that long-term anabolic steroid users had reduced left ventricular ejection fraction and increased myocardial fibrosis compared to age-matched non-users and endurance athletes. Those structural changes do not show up on a standard bloodwork panel. Separately, Rasmussen et al. (2021, European Heart Journal) tracked 545 male strength athletes over 10 years and found anabolic steroid users had a 4.3 times higher risk of major adverse cardiovascular events. On the lipid side, the data is consistent: supraphysiologic testosterone doses reliably suppress HDL cholesterol by 20-50% depending on compound and dose, per Bhasin et al. (2001, NEJM). That suppression does show up in labs, which is why lipid monitoring has real value. But catching a bad lipid panel mid-cycle does not reverse the arterial damage accumulating in parallel.
Where does the social media noise diverge from clinical reality?
Gym TikTok treats bloodwork as a permission slip. The logic goes: if your CBC, CMP, lipid panel, and testosterone numbers look acceptable, you are managing your cycle responsibly. That framework collapses when you look at what standard panels miss. Echocardiography, cardiac MRI, and coronary artery calcium scoring are the tools that would actually detect early androgen-induced cardiac pathology, and no fitness influencer is recommending those. There is also the hematocrit question. A common piece of advice in this content category is to donate blood when hematocrit climbs above 50-52%. That practice is not clinically validated as a cardiovascular risk mitigation strategy for steroid-induced erythrocytosis. Tremblay and Bhatt (2022, Canadian Journal of Cardiology) note that the evidence base for therapeutic phlebotomy in this population is essentially anecdotal. The DM consultation offer is its own problem. Interpreting bloodwork for someone using supraphysiologic androgens without a clinical exam, full medication history, and physician oversight is not harm reduction. It is practicing medicine without a license, regardless of how detailed the TikTok is.
What should you actually know?
Bloodwork before, during, and after an anabolic steroid cycle does have genuine value. A pre-cycle baseline establishes your individual normal ranges for testosterone, LH, FSH, hematocrit, liver enzymes, and lipids, which makes it easier to detect deviations. Hematocrit monitoring during a cycle is particularly relevant because erythrocytosis raises viscosity and thrombotic risk. Liver enzyme monitoring matters most with 17-alpha-alkylated oral compounds like oxandrolone or stanozolol. Post-cycle FSH and LH recovery is a legitimate marker of hypothalamic-pituitary-gonadal axis restoration. None of that is bad advice. The problem is the confidence gap between what a panel tells you and what is actually happening in your vasculature and myocardium. If you are using or considering anabolic steroids, the only clinician worth consulting is one who can order imaging, not just labs, and who will not simply tell you what you want to hear. TikTok DMs are not that clinician.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Bloodwork before a steroid cycle: what the labs actually show, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Bloodwork before a steroid cycle: what the labs actually show is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Supraphysiologic androgen use causes cardiovascular and endocrine effects that standard bloodwork panels only partially capture.
FormBlends verdict
Supraphysiologic androgen use causes cardiovascular and endocrine effects that standard bloodwork panels only partially capture. Cardiac MRI and echocardiography data show structural myocardial changes in long-term users that are invisible to a CBC or CMP. Physician-supervised monitoring with appropriate imaging is the clinical standard; social media bloodwork interpretation is not a substitute.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Supraphysiologic androgen use causes cardiovascular and endocrine effects that standard bloodwork panels only partially capture. Cardiac MRI and echocardiography data show structural myocardial changes in long-term users that are invisible to a CBC or CMP. Physician-supervised monitoring with appropriate imaging is the clinical standard; social media bloodwork interpretation is not a substitute.
- Standard pre-cycle bloodwork panels miss the cardiac structural changes that cardiac MRI and echocardiography detect, including myocardial fibrosis documented by Baggish et al. (2017, Circulation).
- Supraphysiologic testosterone reliably suppresses HDL cholesterol by 20-50% depending on compound and dose, per Bhasin et al. (2001, NEJM), making lipid monitoring one of the more actionable lab markers.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Standard pre-cycle bloodwork panels miss the cardiac structural changes that cardiac MRI and echocardiography detect, including myocardial fibrosis documented by Baggish et al. (2017, Circulation).
- Supraphysiologic testosterone reliably suppresses HDL cholesterol by 20-50% depending on compound and dose, per Bhasin et al. (2001, NEJM), making lipid monitoring one of the more actionable lab markers.
- Long-term anabolic steroid users face a 4.3-fold higher risk of major adverse cardiovascular events compared to non-users, according to a 10-year prospective study by Rasmussen et al. (2021, European Heart Journal).
- Hematocrit monitoring during a cycle has real clinical rationale since erythrocytosis raises blood viscosity and thrombotic risk, but therapeutic phlebotomy as a fix lacks a solid evidence base in this population.
- Post-cycle LH and FSH testing is a legitimate way to assess hypothalamic-pituitary-gonadal axis recovery, but timelines for recovery vary widely and are not fully predictable from a single panel.
- Social media DM consultations on bloodwork interpretation are not a substitute for physician oversight and represent a significant liability for both creator and viewer.
- Any responsible monitoring of anabolic steroid use should include imaging-based cardiovascular assessment, not bloodwork alone.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
thegorillapharma_ · TikTok creator
38.7K views on this video
If you're using steroids without bloodwork, you're flying blind. Learn what tests you need before, during, and after your cycle to stay healthy and make adjustments. I'll explain what those numbers actually mean and how to interpret your results. Need help understanding your specific bloodwork? DM me @TheGorillapharma for personalized analysis and guidance. #gym #gymtok #health #bloodwork #gymrat
Sources & references
- [1]Baggish et al. (2017)
- [2]Rasmussen et al. (2021)
- [3]Bhasin et al. (2001)
- [4]Tremblay and Bhatt (2022)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by thegorillapharma_, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.